Sissetulev dokumentAvalik
Infokiri
Terviseamet · 17. märts 2025
- Viit
- 8-2/25/1945-1
- Registreeritud
- 17. märts 2025
- Dokumendi liik
- Sissetulev dokument
- Adressaat
- ECDC respiratory viruses
- Saabumis/saatmisviis
- e-post
- Funktsioon
- 8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine
- Sari
- 8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus
- Toimik
- 8-2/2025
- Vastutaja
- Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond)
Sisu (failidest)
Saatja: "ECDC respiratory viruses" <[email protected]>
Teema: To NFPs and OCPs FOR ACTION: INFLVIRAGGR, NCOVAGGR and NCOVTEST to be discontinued
Kuupäev: 2025-03-14 16:00
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.
To: National Focal Points for Viral Respiratory Diseases, Operational
Contact Points for COVID-19, Influenza and SARI
Cc: National Coordinators
Dear colleagues,
Thank you to all countries that have transition to the new integrated
recordtypes in TESSy for respiratory surveillance data over the past months!
We want to inform you that it will not be possible to report data beyond
2025-W14 to INFLVIRAGGR, NCOVAGGR and NCOVTEST. Data previously reported to
these recordtypes for 2025-W15 and beyond will need to be reported to
RESPIAGGR, RESPISEVERE and/or RESPISURV.
For those countries that have not transitioned, please make sure to move
reporting to RESPIAGGR, RESPISEVERE and/or RESPISURV as soon as possible.
The European Centre for Disease Prevention and Control (ECDC) and the WHO
Regional Office for Europe (WHO/Europe) continue to be available to assist
in case you have any questions about the transition.
Updating historic data in INFLVIRAGGR, NCOVAGGR and NCOVTEST will remain
possible until mid-May. After mid-May, the historic data in the old
recordtypes will be frozen and any historic updates would need to be made
through the new recordtypes.
Please do not hesitate to contact us at
<mailto:[email protected]> [email protected] and
[email protected] <mailto:[email protected]> with any questions or
concerns.
Kind regards,
The WHO/Europe and ECDC Respiratory Virus Surveillance Teams
Classified as ECDC NORMAL
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly
requested, to, consecutively, refrain from disclosing its content to any
third party, delete it and inform its sender of the erroneous transmittal.
Classified as ECDC NORMAL